BIOMAT Database Logo BIOMAT Database Logo

[Gynecomastia in spironolactone therapy]. 1979

H Vetter

UI MeSH Term Description Entries
D008297 Male Males
D006177 Gynecomastia Enlargement of the BREAST in the males, caused by an excess of ESTROGENS. Physiological gynecomastia is normally observed in NEWBORNS; ADOLESCENT; and AGING males. Adolescent Gynecomastia,Infant Gynecomastia,Male Breast Enlargement,Newborn Gynecomastia,Breast Enlargement, Male,Enlargement, Male Breast,Gynecomastia, Adolescent,Gynecomastia, Infant,Gynecomastia, Newborn
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013148 Spironolactone A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827) Spirolactone,Aldactone,Aldactone A,Aquareduct,Duraspiron,Espironolactona Alter,Espironolactona Mundogen,Flumach,Frumikal,Jenaspiron,Novo-Spiroton,Practon,SC-9420,Spiractin,Spiro L.U.T.,Spiro Von Ct,Spirobeta,Spirogamma,Spirolang,Spirono-Isis,Spironone,Spirospare,Veroshpiron,Verospiron,Verospirone,Ct, Spiro Von,Novo Spiroton,NovoSpiroton,SC 9420,SC9420,Spirono Isis,Von Ct, Spiro

Related Publications

H Vetter
SPIRONOLACTONE THERAPY AND GYNECOMASTIA.
July 1965, JAMA,
H Vetter
Gynecomastia and impotence: complications of spironolactone therapy.
January 1973, JAMA,
H Vetter
Spironolactone-induced gynecomastia.
February 2007, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne,
H Vetter
Spironolactone-Induced Unilateral Gynecomastia.
January 2018, International journal of applied & basic medical research,
H Vetter
Pathophysiology of spironolactone-induced gynecomastia.
October 1977, Annals of internal medicine,
H Vetter
Gynecomastia induced in normal males by spironolactone.
October 1978, Clinical pharmacology and therapeutics,
H Vetter
Disappearance of spironolactone-induced gynecomastia with triamteren.
June 2001, Internal medicine (Tokyo, Japan),
H Vetter
Gynecomastia and semen abnormalities induced by spironolactone in normal men.
August 1977, The Journal of clinical endocrinology and metabolism,
H Vetter
Unilateral gynecomastia and impotence during low-dose spironolactone administration in men.
June 1975, Military medicine,
H Vetter
Ga-67 citrate and F-18 FDG uptake in spironolactone-induced gynecomastia.
February 2005, Clinical nuclear medicine,
Copied contents to your clipboard!